Over a dozen UBLs in higher eukaryotes function by covalently modifying myriad substrates 1 . The best-understood functional consequence of UBL modification is ubiquitin-mediated proteolysis. However, different UBLs alter the functions of their targets in different ways, for example by changing the target's subcellular localization, enzymatic activity or protein-protein interactions. Ubiquitin's closest relative, NEDD8, does not direct its targets to the proteasome. Rather, NEDD8 is conjugated to the cullin subunits of SCF (Skp1-cullin-F-box) and related ubiquitin ligases to alter their activity [2] [3] [4] . NEDD8 enhances the ability of SCF to multiubiquitinate substrates, and displaces the CAND1 inhibitor of SCF assembly [5] [6] [7] [8] . The NEDD8 pathway is essential in organisms ranging from fission yeast to mammals 9,10 , and regulates many important biological processes, including cell division 2,3,11 , signal transduction 5 and development 12 .
Nonetheless, the selective coordination of enzymes within a particular UBL's cascade remains incompletely understood. Particularly lacking is knowledge of unique protein-protein interactions distinct for the cascades for different UBLs. The NEDD8 pathway has served as a good model for studying UBL-specific proteinprotein interaction 26, 51 . Although the enzymes in the NEDD8 pathway are related to those in other UBL transfer cascades, the NEDD8 pathway involves one E1, one E2 and a few E3s 3, 4, 27 . Moreover, it seems that NEDD8 is ultimately directed to a small number of targets [2] [3] [4] . By contrast, the ubiquitin pathway involves tens of E2s, hundreds of E3s and thousands of targets. Thus, the relatively minimal nature of the NEDD8 pathway simplifies the identification of protein-protein interactions specific for a particular UBL's conjugation cascade.
NEDD8's E2, Ubc12, has a 26-residue N-terminal extension upstream of its ∼150-residue conserved E2 core domain. Ubc12's N-terminal extension is unique to the NEDD8 pathway: Ubc12's N-terminal sequence is conserved across species, but is not found in other E2s. The function of Ubc12's N-terminal extension has remained unknown. In this study we found a role for Ubc12's N-terminal extension in cell proliferation: wild-type Ubc12, but not a mutant lacking the N-terminal extension, rescues CSF-1-dependent proliferation of NIH 3T3 cells expressing a mitogenically defective but survival-competent human CSF-1 receptor. Biochemical and X-ray crystallographic studies collectively show that Ubc12's N-terminal extension is a selective peptide motif that optimally recruits NEDD8's E1 for the NEDD8 transfer cascade.
RESULTS

Ubc12's N-terminal extension is important for function
The sequence of Ubc12 has two regions: (i) a unique 26-residue N-terminal extension found only in Ubc12 family members and (ii) an E2 core domain, a ∼150-residue domain conserved among all E2s, which contains the E2 catalytic cysteine (Fig. 1a) . To assess whether Ubc12's N-terminal extension has any functional importance, we tested the function of a deletion mutant lacking residues 2-26, termed Ubc12∆N, using a biochemical assay for NEDD8 transfer. The ultimate targets of NEDD8 modification include cullin family members 2-4 such as human Cul1. Cul1 is modified by NEDD8 at a single lysine, Lys720 (ref. 27 ). The NEDD8 transfer cascade can be reconstituted in vitro with the APPBP1-UBA3 heterodimeric E1 complex, the E2 Ubc12, the E3 Rbx1, the target Cul1, NEDD8, Mg 2+ and ATP 27 ( Fig. 1b) . We monitored NEDD8 transfer using 32 P-labeled NEDD8 phosphorylated at an N-terminal protein kinase A site with [γ-32 P]ATP 28 . We found that deleting Ubc12's N-terminal extension substantially hindered Ubc12's ability to transfer NEDD8 to Cul1's Lys720 (Fig. 1c) .
We next assayed the importance of Ubc12's N-terminal extension in cell proliferation. The NEDD8 pathway enzymes play an essential role in cell proliferation in organisms ranging from fission yeast to mammals 9, 10 . Consistent with this function, we identified Ubc12 in a genetic screen for proteins involved in cell proliferation (R.M and M.F.R., unpublished results). This same screen previously identified cell cycle regulatory proteins such as Myc and D-type cyclins 29, 30 . Therefore, we assayed Ubc12's effects on cell proliferation as follows: ectopic expression of the human macrophage colony-stimulating factor 1 (CSF-1) receptor (CSF-1R) in NIH 3T3 mouse fibroblasts allows the cells to survive, migrate and proliferate in serum-free medium and form colonies in soft agar the presence of human CSF-1 as the sole growth factor 31 . By contrast, cells expressing CSF-1R with the Y809F mutation in the T loop survive and remain arrested in G1, but fail to proliferate and form colonies in soft agar when stimulated with the CSF-1 growth factor 29 . As with Myc and D-type cyclins 29, 30 , which are other regulators of mitogenesis, retroviral expression of Ubc12 in these cells allowed proliferation in soft agar in the presence of human CSF-1 (Fig. 1d,e) . Unlike wild-type Ubc12, Ubc12∆N did not support proliferation, even though the wild-type and mutant Ubc12 proteins were expressed at similar levels (Fig. 1d,e) . Therefore, the N-terminal extension of Ubc12 plays an important role in mitogenesis, as well as in vitro.
Ubc12's N-extension interacts selectively with NEDD8's E1
We next sought to identify the biochemical basis for Ubc12∆N's defect in NEDD8 transfer. Ubc12 is involved in multiple steps in NEDD8 transfer: (i) interaction with NEDD8's E1, the APPBP1-UBA3 complex (ii) receiving NEDD8 from APPBP1-UBA3's catalytic cysteine in a transthiolation reaction (iii) interaction with the RING E3 Rbx1, and finally (iv) conjugation of NEDD8 to Cul-1's Lys720. To identify whether Ubc12∆N is defective at the first two steps in the reaction, we carried out kinetic analyses, monitoring the initial rate of APPBP1-UBA3-dependent transfer of 32 P-labeled NEDD8 onto Ubc12's catalytic cysteine, as a function of Ubc12 concentration (Fig. 2a) . The k cat values for forming the Ubc12-NEDD8 and Ubc12∆N-NEDD8 thioester complexes were similar, suggesting that Ubc12∆N is chemically competent for the transthiolation reaction (Supplementary Table 1 online). However, the K m for Ubc12∆N (209 ± 11 nM) is ∼25-fold higher than that of wild type (5,150 ± 153 nM), indicating a defect in binding to APPBP1-UBA3 (Supplementary Table 1 online) .
To test whether Ubc12∆N is competent to transfer NEDD8 to Cul1, we examined Ubc12∆N-mediated formation of the Cul1-NEDD8 complex in the presence of increased APPBP1-UBA3. These experiments were done at identical concentrations of NEDD8, Ubc12, Ubc12∆N and Rbx1-Cul1, with the only difference being the concentration of the APPBP1-UBA3 E1 complex. Twenty-fold higher levels of the APPBP1-UBA3 E1 complex were sufficient to allow Ubc12∆N to form a thioester intermediate with NEDD8, and to ligate NEDD8 to Cul1 to the same degree as wild-type Ubc12 (Fig. 2b) . These results suggest that Ubc12∆N's primary defect in the NEDD8 pathway arises from its decreased binding to E1. We tested direct binding to APPBP1-UBA3 with a 26-residue synthetic peptide corresponding to the sequence of Ubc12's N-terminal extension, referred to as Ubc12N26. A peptide with identical composition but scrambled sequence was used as a control (ScrambledN26). Ubc12N26 competitively inhibited formation of the Ubc12-NEDD8 thioester with a K i of 22 µM, whereas the scrambled control peptide had no effect (Fig. 2c,d ). The Ubc12N26 peptide had no effect on Ubc12∆N-NEDD8 thioester formation, nor on the ability of the E1s for ubiquitin and Sumo to catalyze E2-ubiquitin and E2-Sumo thioester formation (Fig. 2c) . In addition, deletion of Ubc12's N-terminal extension eliminated Ubc12's ability to coelute with APPBP1-UBA3 during gel filtration chromatography (data not shown). These findings suggest that Ubc12's N-terminal extension binds directly and selectively to APPBP1-UBA3.
Overall structure of the Ubc12N26 complex with NEDD8's E1
To understand how Ubc12's N-terminal extension interacts with APPBP1-UBA3, we determined the crystal structure of the APPBP1-UBA3-Ubc12N26 complex at a resolution of 2.6 Å (Fig. 3 and Table 1 ). Structures of NEDD8's heterodimeric E1, the APPBP1-UBA3 complex, alone and in complex with NEDD8 and ATP, have been determined previously 26, 28 . The previous structures reveal that the E1 contains three domains. An adenylation domain containing the ATP-binding site is linked through flexible loops to a domain organized around the catalytic cysteine, and to the C-terminal domain, which is also involved in E2 binding. The domains are organized around two clefts in the middle (Fig. 4) . From the direction facing the catalytic cysteine, with the catalytic cysteine domain located above the adenylation domain, cleft 1 is on the left and cleft 2 is on the right (Fig. 4, middle panels) . The large size of the two clefts suggested that they accommodated the E1's substrates 28 , and the structure of the APPBP1-UBA3-NEDD8-ATP complex revealed ATP binding in cleft 1 and the globular domain of NEDD8 binding in cleft 2 (ref. 26 ). There are no substantial conformational changes in structure of APPBP1-UBA3 upon Ubc12N26 peptide binding (r.m.s. deviation of 0.517 Å over 917 Cα atoms between apo APPBP1-UBA3 (ref. 28 ) and APPBP1-UBA3-Ubc12N26).
In the APPBP1-UBA3-Ubc12N26 peptide complex, residues 1-13 of the Ubc12N26 peptide are ordered and adopt an extended structure. The Ubc12N26 peptide docks in a groove in the adenylation domain portion of UBA3 (Fig. 4) . This portion of UBA3 has a central eight-stranded mixed β-sheet (strands a-d and g-j). In the previous APPBP1-UBA3-NEDD8-ATP structure, ATP and NEDD8 bind across one surface of the sheet, facing the catalytic cysteine domain. The Ubc12N26 peptide binds across the opposite face of the β-sheet. The N terminus of Ubc12 approaches the edge of the sheet nearest the binding site for NEDD8's globular domain. The observed C terminus of the peptide (Ubc12's residue 13) approaches the edge of the sheet near the ATP-binding site, and is ∼55 Å from UBA3's catalytic cysteine. The peptide-binding groove is produced by the splayed-apart ends of β-strands a, d and g-j (Fig. 4 , top left panel). The 'top' side of the peptide-binding groove comes from loops at the N termini of β-strands d and g and at the C termini of β-strands h and j. The 'bottom' side of the groove is formed by UBA3's helix 2 and the N terminus of the subsequent β-strand a, and the loop preceding β-strand i.
Structural basis for selective interactions with Ubc12N26
To understand the selectivity of Ubc12's N-terminal extension toward NEDD8's E1, we examined the conservation of the E1 docking groove in the sequences of other UBL-activating enzymes. We aligned the sequence of the Ubc12N26-binding domain of UBA3 (residues 9-205 and 288-346) with the corresponding sequences either in UBA3s from different species, or in activating enzymes for the following UBLs: human ubiquitin, Sumo and ISG15, Escherichia coli MoaD and ThiF, and Saccharomyces cerevisiae Apg8p and Urm1p. There is a high degree of conservation in the binding groove for Ubc12's N-terminal extension among UBA3 family members from different species (Fig. 5) . However, the groove is poorly conserved among activating enzymes for different UBLs, explaining the lack of interaction we observe between the Ubc12N26 peptide and the E1s of ubiquitin and Sumo. Thus, the structure of the APPBP1-UBA3-Ubc12N26 peptide complex reveals how, within the conserved structural scaffold of an E1, unique surfaces can be generated that mediate distinct, specific protein-protein interactions.
The Ubc12N26-UBA3 interface
The extended conformation of the Ubc12N26 peptide is stabilized by numerous hydrogen bonds between UBA3 and the peptide backbone, burying 950 Å 2 of the Ubc12N26 peptide's surface area. The complex is anchored by burial of two hydrophobic residues from Ubc12, Phe5 and Leu7, in a broad cavity on the top side of the groove (Fig. 6a) . In contrast to the Ubc12 portion of this interaction, which is dominated by only two hydrophobic side chains, the UBA3 portion of this interaction involves numerous residues. UBA3's Phe44, Cys49, His139, Ile140, Pro171, Ile174, Pro176, Leu193, Met196, Ile310, Ala311 and Pro317 line the broad cavity that interacts with Ubc12N26's Phe5 and Leu7. Facing the opposite, bottom side of the groove, Ubc12's Leu4 makes hydrophobic contacts with UBA3's His32, Pro33 and Ile316, and Ubc12's Ser6 forms a hydrogen bond with UBA3's Ser313. The observed portion of the peptide sequence is anchored at both ends, with Ubc12's N-terminal Met1 tucking into one end of UBA3's broad hydrophobic cavity, and Lys12's side chain forming hydrogen bonds with the carbonyls from UBA3's Arg136 and Phe138.
The roles of individual residues in Ubc12's N-terminal extension were assessed by testing the effects of single alanine substitutions on Ubc12-NEDD8 thioester formation. Mutations of Phe5 and Leu7 have the greatest effect ( Fig. 6b and Supplementary Table 1 online) , indicating that the burial of these hydrophobic side chains contributes the bulk of the binding energy. Smaller effects result from mutating Leu4 and Lys12. The F5A L7A double mutation results in a ∼20-fold increase in K m , and the triple mutant, which also contains a L4A substitution, has the same effect on K m as deleting the entire 26-residue N-terminal extension ( Fig. 6b and Supplementary Table 1 online) . Leu4, Phe5 and Leu7 are conserved as hydrophobic residues among Ubc12 family members from different species, suggesting that their N-terminal extensions will bind their UBA3s in a similar manner.
The broad cavity from UBA3 that recognizes Ubc12's Phe5 and Leu7 involves numerous hydrophobic side chains. The roles of different parts of UBA3's cavity were tested by assaying the effects of mutating side chains from different regions of the groove (Fig. 6c and Supplementary  Table 1 online) . All of the mutations affect the K m for Ubc12-NEDD8 thioester formation without affecting k cat . The binding affinity for Ubc12 in the transthiolation reaction further decreases as the number of mutations increases, reflecting the importance of UBA3's entire broad cavity in recognizing Ubc12's N-terminal extension.
Optimal spacing between Ubc12's N-extension and core domain If Ubc12's N-terminal peptide and E2 core domain bind the E1 simultaneously, then there should be a minimal length requirement for the linker between the two domains of Ubc12. To address this possibility, we made deletions and insertions between Ubc12's residues 16 and 23 based on (i) the location of these residues in the sequence, between Ubc12's N-terminal residues ordered in the crystal structure (residues 1-13) and E2 core domain (Ubc12 residues 27-183); (ii) the low sequence complexity of these residues (sequence SAGGTKG); and (iii) the finding that mutating the Leu4, Phe5 and Leu7 side chains has the same effect as deleting the entire N-terminal peptide, suggesting that no other side chains contribute substantially to the binding of Ubc12's N-terminal 26 residues. Insertions of up to seven glycine and serine residues and deletions of up to five residues had little effect on the kinetics of Ubc12-NEDD8 thioester formation. Removing six residues had a small effect ( Fig. 7 and Supplementary Table 1 online) . In contrast, deleting seven residues was highly detrimental (Fig. 7 and Supplementary Table 1 online). To control for sequence effects, we tested the activity of a four-residue deletion with three flanking residues mutated to alanines (∆4A3, Fig. 7b,c) . The results indicate that there is not a requirement for the sequence removed in the sevenresidue deletion (Fig. 7 and Supplementary Table 1 online) . Therefore, the deleterious effect of the seven-residue deletion reflects a minimum length requirement between Ubc12's E1-docking peptide and E2 core domain.
In contrast to removal of the entire peptide extension, which affects only K m , the deletion of the seven-residue linker affected both K m and k cat . This was probably caused by a combination of two effects. First, formation of the productive complex would involve Ubc12's catalytic cysteine approaching APPBP1-UBA3's catalytic cysteine (Fig. 8a) . In the seven-residue deletion mutant, the linker between Ubc12's catalytic cysteine-containing E2 core domain and N-terminal docking sequence is too short to allow docking of the peptide in the productive complex (Fig. 8b, left panel) . Second, docking of Ubc12's N-terminal peptide in the seven-residue deletion mutant would prevent proper docking of the E2 core domain (Fig. 8b, right panel) . Thus, the interaction of Ubc12 with APPBP1-UBA3 is bipartite: both Ubc12's N-terminal peptide and conserved E2 core domain bind the E1 simultaneously for optimal Ubc12-NEDD8 thioester formation.
The distance between Ubc12's docking peptide and E2 core domain can be estimated based on the minimum number of linker residues required for optimal activity. With an approximation of 3.5 Å per residue for an extended conformation and a minimum requirement for eight linker residues (equivalent to the five-residue deletion), the distance is ∼28 Å between the C terminus of the docking peptide and N terminus of the E2 core domain. With the additional constraint that the E1 and E2 catalytic cysteines will be in proximity in the productive complex, the most likely location for the conserved catalytic E2 core domain to bind the E1 structure is in cleft 1 (Fig. 8) .
DISCUSSION
We find that Ubc12's unique N-terminal extension tethers Ubc12 selectively to APPBP1-UBA3 via a novel type of E1-E2 interaction. First, deletion of Ubc12's N-terminal extension reduces the K m , but not the k cat , for APPBP1-UBA3-catalyzed Ubc12-NEDD8 thioester formation. Second, a peptide corresponding to Ubc12's N-terminal 26 residues inhibits NEDD8-Ubc12 thioester formation. This effect is specific to the NEDD8 pathway, because the peptide does not affect thioester formation between ubiquitin or Sumo and their E2s (Fig. 2c) . Third, deletion mutations reveal a minimum length requirement for the linker between Ubc12's docking peptide and E2 core domain. These results suggest that for the NEDD8 pathway, the E1-E2 interaction is bipartite: both Ubc12's docking peptide and catalytic core domain must bind the E1 simultaneously for optimal transfer of NEDD8 from E1 to E2.
The crystal structure of the APPBP1-UBA3-Ubc12N26 peptide complex reveals that Ubc12's peptide-like extension interacts with a docking groove generated from unique loop sequences in UBA3. Even though the docking peptide and docking groove sequences are unique to Ubc12 and UBA3 family members, respectively, the adenylation domain portion of UBA3 that contains the docking groove corresponds to the most conserved domain in UBL-activating enzymes 13, 32 . Thus, the structure reveals how unique protein-protein interactions,
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Figure 8
Model for optimal positioning of Ubc12 in the E1 structure for formation of the Ubc12-NEDD8 thioester. APPBP1 is blue, UBA3 is red, NEDD8 is yellow, Ubc12 is cyan, and catalytic cysteines are green.
(a) Ubc12's interaction with APPBP1-UBA3 is bipartite: both Ubc12's N-terminal peptide and conserved E2 core domain must bind the E1 simultaneously for optimal Ubc12-NEDD8 thioester formation. (b) Deletions of six or more residues from the linker between Ubc12's N-terminal docking peptide and E2 core domain are deleterious, either preventing docking of the N-terminal docking sequence (left) or the E2 core domain (right). The minimum length of 8 residues between Ubc12's N-terminal 13-residue docking peptide and E2 core domain suggests that the E2 core domain binds cleft 1 in the APPBP1-UBA3 structure.
specific for a particular UBL's pathway, can be generated from a common structural scaffold such as an E1 adenylation domain. Many post-translational modifications are directed to their targets via multienzyme cascades. In addition to UBL modification cascades, some of the best-studied examples of multienzyme post-translational modification cascades are serine/threonine phosphorylation pathways, such as MAP kinase (MAPK) and cyclin-dependent kinase (CDK) cascades. Several characteristics of the interaction between NEDD8's E1 and the peptide from NEDD8's E2 are reminiscent of interactions in these pathways. MAPKs and CDKs bind their targets through interactions between docking peptides and docking grooves 33, 34 . Similar to APPBP1-UBA3's interactions with Ubc12, the interactions of MAPKs and CDKs with the downstream enzymes in their cascades are often bipartite, with both a docking peptide binding distal from the active site and the target's phosphoacceptor sequence binding at the kinase active site. A primary function of the docking peptide interaction with these kinases is to reduce the K m of the target 35 . Thus, the APPBP1-UBA3-Ubc12N26 interaction reveals that common design principles underlie these very divergent multienzyme post-translational modification cascades.
The interaction between E1 and the E2's N-terminal peptide found between APPBP1-UBA3 and Ubc12 is probably unique to the NEDD8 pathway, because many E2s for other UBLs lack N-terminal extensions. We wonder why the NEDD8 cascade requires additional E1-E2 interactions. Clues to a possible function for this interaction come from the paradigm of interactions between docking grooves and docking peptides established by serine/threonine phosphorylation cascades. In MAPK or CDK cascades, the kinase docking groove is multifunctional, recruiting not only targets, but also regulatory proteins such as other kinases, phosphatases and inhibitors, which all contain similar docking peptide sequences 33, 34 . For example, part of the function of some CDK inhibitors comes from their ability to displace peptide-like docking sequences in substrates 33 . Notably, a UBA3-binding protein, But1, has recently been identified in fission yeast 36 . But1's biological function is consistent with an inhibitory role in the NEDD8 pathway 36 . The But1 sequence contains many Φ-Φ-X-Φ (where Φ indicates a hydrophobic residue and X indicates any residue) sequences similar to the Leu4-Phe5-Ser6-Leu7 sequence, which we find anchors Ubc12 in UBA3's docking groove. Future studies will reveal whether But1 or other proteins bind to UBA3 via the Ubc12 docking groove to inhibit NEDD8 conjugation.
Another possible function for the additional APPBP1-UBA3-Ubc12N26 interaction comes from the marked specificity of the NEDD8 pathway [2] [3] [4] . NEDD8 modification of cullins is one of many regulatory mechanisms controlling ubiquitin conjugation by SCF and related E3s. Consistent with its important regulatory function, NEDD8 modification of cullins is controlled not only by the conjugation pathway, but also by deconjugation by the COP9 signalosome 37 , underscoring the importance of precision in this pathway. The additional E1-E2 interaction may serve to ensure the selectivity of the NEDD8 conjugation cascade.
Like Ubc12, many other E2s also have their own distinct extensions at their N and C termini, beyond the conserved E2 core domain. The molecular functions of only a handful of these extensions are known [38] [39] [40] [41] , and to date, the structural basis for protein-protein interactions mediated by these extensions remains elusive. One of the bestunderstood extensions is in the E2 Ubc2p, which interacts with the E3 Ubr1p. Although the Ubc2p-Ubr1p interaction is likely to involve interactions common to E2-E3 complexes because it requires Ubr1p's RING domain, Ubc2p's C-terminal extension is also known to stabilize the interaction with Ubr1p 42 . Therefore, it is likely that the extensions on other E2s function in a manner analogous to Ubc12's, strengthening interactions between enzymes in other UBL modification cascades.
The importance of Ubc12's N-terminal extension is further underscored by the detrimental effect of the Ubc12∆N deletion in our cell proliferation assay. The best-characterized targets of Ubc12 are cullins [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 43 , although we do not yet know which targets are important in our assay. Cul1-, Cul2-, Cul3-and Cul4a-containing ubiquitin ligases are known to promote the degradation of key regulators of cell proliferation, including cyclins, CDK inhibitors, proteins involved in DNA replication, proteins involved in mitotic spindle assembly, transcription factors and proteins involved in signal transduction (reviewed in ref. 43 ). It will be of interest to determine which targets of Ubc12-mediated NEDD8 conjugation are involved in the CSF-1-dependent proliferation. Our finding that Ubc12∆N is defective in this cell proliferation assay raises the possibility that APPBP1-UBA3 and Ubc12 may serve as good targets for antimitogenic agents.
METHODS
Protein and peptide preparation. All constructs were generated by standard PCR-ligation molecular biology methods. The entire coding sequence for each construct was verified by automated sequencing. All proteins were expressed as GST fusions in E. coli strains BL21(DE3), BL21Gold(DE3), or BL21(DE3) RIL codon-enhanced strains (Novagen and Stratagene), from either pGEX4T1 or pGEX2TK (Pharmacia). The proteins were initially purified as GST fusions by glutathione affinity chromatography, and were subsequently purified to homogeneity after thrombin cleavage using a combination of ion exchange, gel filtration and glutathione affinity chromatography 26, 28, 44, 45 . A mutant form of APPBP1-UBA3 lacking APPBP1's loop of residues 254-258 and UBA3's N-terminal 11 residues, with UBA3's catalytic Cys216 mutated to alanine, was , and Cul1's C-terminal domain (residues 411-776 at the C terminus). The complex consists of Cul1's N-and C-terminal domains associated noncovalently with each other and with Rbx1. The split Cul1-Rbx1 complex has been shown previously to have the same three-dimensional structure and ubiquitin ligase activity as the Rbx1 complex with Cul1 expressed as a single polypeptide in insect cells 45 . The 26-residue peptide corresponding to Ubc12's N terminus, termed Ubc12N26 (sequence MIKLFSLKQQKKEEESAGGTKGSSKK), the five different selenomethoionine (SeMet)-substituted Ubc12N26 peptides, and the ScrambledN26 peptide (sequence MKFQLKEIEAGKSKLKSGTSEKGQKS) were chemically synthesized with C-terminal amide blocking groups. The peptides were purified by reverse-phase HPLC, and their identities confirmed by mass spectrometry. The lyophilized peptides were dissolved in 25 mM HEPES, 150 mM NaCl, 5 mM DTT, pH 7.5, at a concentration of 10 mM.
Biochemical assays. All biochemical assays were carried out in 10 µl in 50 mM Tris-HCl, pH 7.6, 50 mM NaCl, 10 mM MgCl 2 , 5 mM ATP, 1 mM DTT, 0.3 U ml -1 inorganic pyrophosphatase, 0.3 U ml -1 creatine phosphatase, 5 mM creatine phosphate, 2 mg ml -1 ovalbumin, with 5 µM NEDD8, ubiquitin or S. cerevisiae Sumo (Smt3p) phosphorylated at the N-terminal PKA site (from pGEX2TK) with [γ-32 P]ATP 28 , at 18 °C, which is the ambient room temperature for our dedicated radioactivity laboratory. Reactions were quenched with an equal volume of 2× SDS sample buffer. Reactions were carried out with 1 nM of the appropriate E1, except for the modification of Cul1 by Ubc12∆N (Fig. 2) , which used 1, 5, 10, 15 and 20 nM APPBP1-UBA3 as indicated, and 3 µM Rbx1-Cul1. Kinetics of E1-E2 transthiolation were determined from at least seven different Ubc12 concentrations per curve, ranging from 0 to 50 µM, with reactions stopped after 30 s (ref. 46 ). The Cul1 modification and peptide inhibition assays were stopped after 60 s. Proteins were resolved by SDS-PAGE, dried and visualized by autoradiography. Bands were quantified using a STORM860 phosphorimager and ImageQuant software (Molecular Dynamics). Known amounts of 32 P-labeled NEDD8 and [γ-32 P]ATP were exposed together as standards. k cat and K m for E1-E2 transthiolation were determined from Lineweaver-Burk plots. The K i of Ubc12N26 for APPBP1-UBA3-catalyzed Ubc12-NEDD8 thioester formation was determined from five different Ubc12 concentrations (0.1-2 µM) with varying concentrations of Ubc12N26 (0-1 mM), and calculated from Dixon plots using SigmaPlot 8.0 software (SPSS).
Cell culture, antibody production and immunoblotting. NIH 3T3 mouse fibroblast lines expressing the wild-type or mutant (Y809F) human CSF-1 receptors were as described 31 . For identification of Ubc12 in the human CSF-1-dependent mitogenesis assay, cells expressing human CSF-1R Y809F were infected with a retroviral MaRX rat cDNA library provided by G. Hannon (Cold Spring Harbor Laboratory) 47 . Infected cells were plated on 100-mm plates and foci of transformed cells were recovered by cylinder cloning. Integrated proviruses were recovered by digestion of the cell's high-molecularmass DNA with the Cre recombinase, as described 47 , and Ubc12 was recovered multiple times from the soft agar clones. The protein sequences of rat and human Ubc12 are identical, so human Ubc12 and Ubc12∆N were subcloned into the pBabepuro retroviral vector for preparing high-titer retroviruses in 293T cells. NIH 3T3 cells expressing the wild-type or Y809F mutant human CSF-1R were infected with retroviruses expressing Ubc12 or Ubc12∆N, and cloned in soft agar 2 d after infection in the presence or absence of recombinant human CSF-1 (provided by M. Clark, Genetics Institute). Lysates were also prepared in parallel and 24 µg of each protein lysate or 50 ng of purified bacterially produced wild-type or mutant Ubc12 were separated by SDS-PAGE. Proteins were analyzed by immunoblotting, with Ubc12 detected by rabbit polyclonal antiserum raised against residues 169-180 of Ubc12 (sequence RGGYIGSTYFER, generated by Rockland Immunochemicals). Anti-actin serum (C-11, Santa Cruz Biotechnology) was used to control for loading.
Crystallization, data collection and structure determination. APPBP1(∆254-258)-UBA3(∆N11 C216A) and Ubc12N26 were mixed at 1:5 molar ratio, and crystals were grown at room temperature by hanging-and sitting-drop vapor diffusion by mixing the complex with an equal volume of reservoir solution containing 9.5-12.5% (v/v) PEG 10k, 0.2 M KCl, 0.1 M MES, 5 mM DTT, pH 6.5. The crystals formed with two complexes in the asymmetric unit ( Table 1) . Crystals were flash-frozen in 12.5% (v/v) PEG 10k, 0.2 M KCl, 0.1 M MES, 5 mM DTT, 20% (v/v) MPD, pH 6.5, before data collection at the SERCAT beamline at the Advanced Photon Source, at the X25 beamline at the National Synchrotron Light Source, and at the 8.3.1 beamline at the Advanced Light Source. Reflection data were indexed, integrated and scaled using HKL2000 or DENZO and SCALEPACK 48 or Elves 49 . Initial phases were obtained by molecular replacement using Elves 49 with the coordinates of apo APPBP1-UBA3 (ref. 28 ) as a search model, or by refining the apo APPBP1-UBA3 structure against the new data using CNS 50 . Electron density for the peptide was readily visible after preliminary refinement. Because only 13 of the 26 residues in the Ubc12N26 peptide were visible in the structure, we wished to obtain independent experimental data to verify the structure of the peptide. We grew crystals of the complex with individual SeMet substitutions in place of Met1, Ile2, Leu4, Leu7 and Gln10, collected data to better than a resolution of 3.5 Å at the peak wavelength for the incorporated selenium (∼0.9796 Å), and identified the locations of the seleniums by anomalous difference Fourier analysis, with phases obtained by using the apo APPBP1-UBA3 structure 28 as a search model with Elves 49 . Each selenium is located on the assigned side chain in the native structure (Fig. 3a) , providing experimental validation for the structure of the peptide. The final model was refined at a resolution of 2.6 Å using CNS 50 , and it contains two copies of the complex. The electron density is substantially better over one copy, which contains Ubc12N26 residues 1-13, APPBP1 residues 1-253 and 259-534, UBA3 residues 12-355 and 361-384, and an additional 3 residues owing to cloning at the N terminus and 43 residues in the C-terminal domain built as polyalanine, owing to weak side chain density and lack of density for loops precluding unambiguous determination of the side chains in this region. The other copy contains Ubc12N26 residues 4-13, APPBP1 residues 7-199, 211-253 and 259-534, UBA3 residues 17-354 and 361-384, and an additional 33 residues in the C-terminal domain built as polyalanine. Side chains lacking electron density were not modeled. The final model has excellent geometry, with no Ramachandran outliers in disallowed regions. Details of refinement are given in Table 1. Coordinates. Coordinates and structure factors for the APPBP1-UBA3-Ubc12N26 structure have been deposited in the Protein Data Bank (accession code 1TT5). 
